David Krempa, Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON), sold 4,166 shares at $55.07 ($229K) on 2026-10-06, disclosed to the SEC on 2026-10-06.
Open-market sale of $229k ETON by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ETON | SELL | 2025-06-16 | $908K | — | Filing → |